Beijing, China

Lifeng Zhou

This inventor holds 2 USPTO granted patents. Top assignee: Amsinomed Medical Co., Ltd. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lifeng Zhou. Retrieved from https://idiyas.com/inventor/lifeng-zhou-vho7ab9a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lifeng Zhou: Innovator in Biomedical Engineering

Introduction

Lifeng Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of advanced vascular stents. With a total of 2 patents, his work focuses on improving the efficacy and safety of stent technology.

Latest Patents

Zhou's latest patents include a cobalt-chromium alloy stent and a drug-eluting stent. The cobalt-chromium alloy stent comprises several main body units, each made up of supporting rings connected by flexible ribs. The adjacent main body units are linked by connecting ribs. This innovative design enhances the stent's performance. The drug-eluting stent incorporates a drug coating containing arsenic trioxide and tacrolimus. The drug release curves of these composite drugs are adjusted to effectively inhibit the inflammatory response of vascular endothelial cells and the proliferation of vascular smooth muscle cells, thereby reducing the vascular restenosis rate.

Another notable patent is the degradable biomedical magnesium alloy drug-eluting vascular stent and its preparation method. This stent is composed of a magnesium alloy with specific components, including Gd, Y, Li, Zn, and Zr. The design ensures good radial support strength and strain dispersion capability. After applying a protective coating, the corrosion resistance of the magnesium alloy stent is significantly improved. The stent utilizes an arsenic trioxide/rapamycin and tacrolimus composite drug sustained-release system, which adapts to the damage repair process of blood vessels. Implantation results in large animals demonstrate the stent's effectiveness in anti-restenosis treatment.

Career Highlights

Lifeng Zhou is currently employed at Amsinomed Medical Co., Ltd., where he continues to innovate in the field of medical devices. His work has garnered attention for its potential to improve patient outcomes in vascular treatments.

Collaborations

Zhou collaborates with talented colleagues, including Xin Shen and Dongyun Hao, to advance their research and development efforts in biomedical engineering.

Conclusion

Lifeng Zhou's contributions to the field of biomedical engineering, particularly in stent technology, highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to enhancing the safety and effectiveness of vascular treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…